| Trial ID: | L5230 |
| Source ID: | NCT01785043
|
| Associated Drug: |
Liraglutide
|
| Title: |
Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users
|
| Acronym: |
LAED001
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
DIABETES Mellitus Type 2 Not Well Controlled
|
| Interventions: |
DRUG: Liraglutide|DRUG: Sitagliptin
|
| Outcome Measures: |
Primary: Assess the effects on endothelial function of a three month treatment with Liraglutide compared to Sitagliptin., The primary objective is to assess the effects on endothelial function of a three month treatment with Liraglutide compared to Sitagliptin, assessed as the baseline corrected change in endothelial function by flow-mediated vasodilation (FMD) of the brachial artery at 3 months., 3months | Secondary: The evaluation of other emerging potential cardiovascular risk factors, 1. Secondary objectives will include the evaluation of other emerging potential cardiovascular risk factors, such as oxidative stress markers, cytokines, and soluble cell adhesion molecules. 2. The safety profile of both treatment groups will be also evaluated., 3months
|
| Sponsor/Collaborators: |
Sponsor: Anna Cruceta
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
13
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-03
|
| Completion Date: |
2014-09
|
| Results First Posted: |
|
| Last Update Posted: |
2015-09-15
|
| Locations: |
Hospital Clínic de Barcelona, Barcelona, 08036, Spain
|
| URL: |
https://clinicaltrials.gov/show/NCT01785043
|
